Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors
Jia Liu, Malinda Itchins, Adnan Nagrial, Wendy A. Cooper, Madhawa De Silva, Megan Barnet, Winny Varikatt, Vanathi Sivasubramaniam, Alexander Davis, Anthony J. Gill, Prunella Blinman, Kenneth Lee, Rina Hui, Bo Gao, Nick Pavlakis, Stephen Clarke, Jenny Lee, Michael Boyer, Steven Kao
Topics & Concepts
MedicineLung cancerTyrosine kinaseMutantOncologyCancer researchProtein-Tyrosine KinasesInternal medicineTyrosine-kinase inhibitorKinaseCancerReceptorGeneGeneticsBiologyLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment